Insider Transactions in Q1 2024 at A Tyr Pharma Inc (LIFE)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 06
2024
|
Jill Marie Broadfoot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,590
-7.09%
|
$1,590
$1.69 P/Share
|
|
Feb 05
2024
|
Sanjay Shukla President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,375
+8.17%
|
-
|
|
Feb 05
2024
|
Nancy Denyes General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,688
+15.4%
|
-
|
|
Feb 05
2024
|
Jill Marie Broadfoot Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,750
+14.33%
|
-
|